Publicaciones en las que colabora con JOSE MANUEL PORCEL PEREZ (33)

2023

  1. MicroRNAs Present in Malignant Pleural Fluid Increase the Migration of Normal Mesothelial Cells In Vitro and May Help Discriminate between Benign and Malignant Effusions

    International journal of molecular sciences, Vol. 24, Núm. 18

2022

  1. Cell-Free DNA Concentration and Pattern Fragmentation in Pleural Fluid and Plasma to Detect Malignant Effusions

    Annals of the American Thoracic Society

2021

  1. Diving into the pleural fluid: Liquid biopsy for metastatic malignant pleural effusions

    Cancers, Vol. 13, Núm. 11

  2. Prevalence, clinical characteristics, and outcome of pleural effusions in ovarian cancer

    Pleura and Peritoneum, Vol. 6, Núm. 2, pp. 75-81

2020

  1. Predictors of indwelling pleural catheter removal and infection: A single-center experience with 336 procedures

    Journal of Bronchology and Interventional Pulmonology, Vol. 27, Núm. 2, pp. 86-94

2019

  1. Epithelial cell adhesion molecule (EpCAM) from pleural fluid cell lysates is a highly accurate diagnostic biomarker of adenocarcinomatous effusions

    Respirology, Vol. 24, Núm. 8, pp. 799-804

2017

  1. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion

    Lung, Vol. 195, Núm. 6, pp. 775-779

  2. Utilidad de la medición de CEA y CA 15-3 en los exudados pleurales no purulentos para diagnosticar malignidad: experiencia de un único centro

    Archivos de Bronconeumologia, Vol. 53, Núm. 8, pp. 427-431

2016

  1. Identifying thoracic malignancies through pleural fluid biomarkers: A predictive multivariate model

    Medicine (United States), Vol. 95, Núm. 10

2015

  1. Accuracy of fluorodeoxyglucose-PET imaging for differentiating benign from malignant pleural effusions: A meta-analysis

    Chest, Vol. 147, Núm. 2, pp. 502-512

  2. Clinical features and survival of lung cancer patients with pleural effusions

    Respirology, Vol. 20, Núm. 4, pp. 654-659

  3. TTF-1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusions

    Respirology, Vol. 20, Núm. 5, pp. 831-833

2011

  1. Tumor type influences the effectiveness of pleurodesis in malignant effusions

    Lung, Vol. 189, Núm. 2, pp. 151-155

2009

  1. High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions

    European Journal of Internal Medicine, Vol. 20, Núm. 4, pp. 383-386

2008

  1. Prognostic significance of pleural fluid data in patients with malignant effusion

    European Journal of Internal Medicine, Vol. 19, Núm. 5, pp. 334-339

  2. Rentabilidad del estudio citológico del líquido pleural en el derrame maligno

    Anales de Medicina Interna, Vol. 25, Núm. 4, pp. 173-177

2006

  1. Rapid pleurodesis with doxycycline through a small-bore catheter for the treatment of metastatic malignant effusions

    Supportive Care in Cancer, Vol. 14, Núm. 5, pp. 475-478

2005

  1. Soluble oncoprotein 185HER-2 in pleural fluid has limited usefulness for the diagnostic evaluation of malignant effusions

    Clinical Biochemistry, Vol. 38, Núm. 11, pp. 1031-1033

2004

  1. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions

    Chest, Vol. 126, Núm. 6, pp. 1757-1763

2002

  1. Exoftalmos unilateral secundario a metástasis orbitaria como manifestación inicial de un cáncer de mama.

    Anales de Medicina Interna